A detailed history of Manske Wealth Management transactions in Grifols Sa stock. As of the latest transaction made, Manske Wealth Management holds 15,150 shares of GRFS stock, worth $131,956. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,150
Previous 16,950 10.62%
Holding current value
$131,956
Previous $153 Million 1.52%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$8.87 - $10.85 $15,965 - $19,530
-1,800 Reduced 10.62%
15,150 $151 Million
Q1 2025

Nov 12, 2025

SELL
$6.62 - $8.71 $43,692 - $57,486
-6,600 Reduced 28.03%
16,950 $121 Million
Q4 2024

Nov 12, 2025

BUY
$6.99 - $9.55 $164,614 - $224,902
23,550 New
23,550 $175 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.91B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Manske Wealth Management Portfolio

Follow Manske Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manske Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Manske Wealth Management with notifications on news.